Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

NovoLog Mix 50/50 (50% insulin aspart protamine suspension and 50% insulin aspart injection [rDNA origin]
Company:  Novo Nordisk Inc.
Application No.:  021810
Approval Date: 8/26/2008

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

 

Date created: August 13, 2009

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-